Mevalonate Metabolism Orchestrates Platelet Hyperactivation via Protein Prenylation to Aggravate Septic Thrombosis.

Inhibiting the mevalonate pathway reduces platelet hyperactivation and septic thrombosis, with a 50% decrease in thrombosis severity in septic mice.

• Why it matters: Sepsis causes dangerous blood clots due to excessive platelet activation, but current treatments lack targeted strategies to prevent this process.
• What they did: Researchers used platelet-specific mevalonate kinase deficiency mice and prenylation inhibitors like TH-Z145 and TH-Z93 to study their effects on platelet activation and thrombosis during sepsis.
• The result: Blocking the mevalonate pathway significantly suppressed platelet activation and improved survival, highlighting a promising new approach for treating sepsis-related blood clots.